You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 2, February 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, SAN FRANCISCO, CALIF, MAY 21 TO MAY 24, 1989-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Metastatic Potential of Colon Carcinoma

Expression of ABO/Lewis-Related Antigens

Stuart D. Hoff, MD; Tatsuro Irimura, PhD; Yoshifumi Matsushita, MD; David M. Ota, MD; Karen R. Cleary, MD; Sen-itiroh Hakomori, MD

Arch Surg. 1990;125(2):206-209.


Abstract

• Four monoclonal antibodies specific to various Lewisx-related antigens were tested for binding to monolayers and detergent extracts of the human colon carcinoma cell line HT-29 P and its metastatic variant HT-29 LMM. Only monoclonal antibody FH6 (antisialyl-dimeric Lex) bound more to the metastatic variant compared with HT-29 P. Detergent extracts of human tissues were then assayed for their FH6-binding activity. Normal colonic mucosa displayed less FH6 binding than either Dukes stage B or D primary colon carcinomas. Liver metastases from colorectal carcinoma demonstrated greater binding than stage B and stage D primary tumors, and more than normal liver. Expression of sialyl-dimeric Lex increases as the metastatic potential of colorectal carcinomas increases, and is related to the progression of colorectal cancer.

(Arch Surg. 1990;125:206-209)



Author Affiliations

From the Departments of General Surgery (Drs Hoff and Ota), Tumor Biology (Drs Irimura and Matsushita), and Pathology (Dr Cleary), University of Texas M. D. Anderson Cancer Center, Houston, and the Biomembrane Institute and University of Washington, Seattle (Dr Hakomori).


Footnotes

Accepted for publication November 15, 1989.

Read before the annual meeting of the Society of Surgical Oncology, San Francisco, Calif, May 22, 1989.

Reprints requests to the Department of General Surgery, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (Dr Ota).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is Sialyl Lewis x Antigen Expression a Prognostic Factor in Patients With Breast Cancer?
Sozzani et al.
INT J SURG PATHOL 2008;16:365-374.
ABSTRACT  

Expression of Human {{alpha}}(1,3)Fucosyltransferase Antisense Sequences Inhibits Selectin-mediated Adhesion and Liver Metastasis of Colon Carcinoma Cells
Weston et al.
Cancer Res. 1999;59:2127-2135.
ABSTRACT | FULL TEXT  

Adhesion of Head and Neck Squamous Cell Carcinoma to Endothelial Cells: The Missing Links
Wenzel et al.
Arch Otolaryngol Head Neck Surg 1995;121:1279-1286.
ABSTRACT  

Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewis X, and sialyl Lewis a in lung cancer
Ogawa et al.
J. Thorac. Cardiovasc. Surg. 1994;108:329-336.
ABSTRACT | FULL TEXT  

ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex
Phillips et al.
Science 1990;250:1130-1132.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.